
Sign up to save your podcasts
Or


Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.
By Johns Hopkins Kimmel Cancer Center4.6
99 ratings
Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.

32,105 Listeners

40 Listeners

5 Listeners

26 Listeners

828 Listeners

5 Listeners

301 Listeners

112,451 Listeners

56,745 Listeners

322 Listeners

45 Listeners

16 Listeners

2 Listeners

25 Listeners

8,185 Listeners

627 Listeners

58,305 Listeners

155 Listeners

834 Listeners